Unit I KANDLA, GUJARAT Formulation Facility
Facility Capabilities
Dosage form |
Units/Annum |
|---|---|
Tablets |
10 Million |
Coated Tablets |
1 Million |
General Capsules |
788 Million |
β-Lactum Capsules |
613 Million |
Sachet |
221 Million |
β-Lactum dry Syrup |
26 Million |
Vials |
53 Million |
Glass Ampoule |
48 Million |
Plastic Ampoule |
1.5 Million |
Cream & Ointment |
11 Millions |
Approved by
- WHO (India)
- South Africa(MCC/SAHPRA)
- Industry and Trade of the Russian Federation
- Kenya - PPB
- United Arab Emirates Ministry of Health and Prevention
- Medicine Control Authority of Zimbabwe
- ISO (ISO 13485:2016/NS-EN ISO 13485:2016)
- ANVISA-BRAZIL
- Tanzania
- Zimbabwe
- State GMP
- UAE-MOH
Planned by:
- EU
- CANADA
- EAEU
- PIC/S (Ukraine )
- Kenya
- Uganda
- Mexico
Unit II KANDLA, GUJARAT Formulation Facility
Facility Capabilities
Dosage form |
Units/Annum |
|---|---|
Transdermal Patches |
10.8 Million |
GMP certification
- ANVISA-BRAZIL
- TGA
- UAE-MOH
- National Drug Authority
- WHO (India)
- State GMP
Planned by:
- EU
- Russia
DEHRADUN, UTTARAKHAND Formulation Facility
Facility Capabilities
Dosage form |
Units/Annum |
|---|---|
Tablets |
4300 Million |
Capsules |
21 Million |
Sachet |
21 Million |
Transdermal Patches |
8.64 Million |
Granules |
4000 kg |
Vials |
40 Million |
Bottles |
0.1 Million |
Ampoule |
90 Million |
Pre Filled Syring |
15 Million |
Syrup |
9.36 Millions Bottles |
Approved by
- EU (Belgium)
- HEALTH CANADA
- TGA
- ANVISA
- UAE-MOH
- Ukraine – PIC/S
- South Africa(MCC/SAHPRA)
- WHO (India)
- Uganda
- Arab Emirates
- ISO (ISO 13485:2016/NS-EN ISO 13485:2016)
- Tanzania - TFDA
- IDA
- Namibia
- GMP
Planned by:
- UK
- Russia
- Switzerland
- Malaysia
- Philippines
- Kenya
PITHAMPUR,MADHYA PRADESHAPI Facility II
Planned by:
- USFDA
- EUGMP
- WHO (India)
- State GMP
Ankleshwar, GUJARAT API Facility I
Facility Capabilities
Production |
Capacity (KL) |
|---|---|
Plant – I |
13.0KL |
Plant – II |
15.5KL |
Total |
28.5 KL (32Tons ) of annual production |
API Manufacturing facility is Approved by:
- BRAZIL
- HEALTH CANADA
- EDQM - EUROUPE
- EU (Belgium)
- FAMHP- Belgium
- WHO (India)
- State GMP
Planned by:
- USFDA
Business Enquiries and Contact Information
Our Office
Rusan Pharma Ltd
58-D, Government Industrial Estate,
Charkop, Kandivali (West),
Mumbai - 400 067
Maharashtra. India
Copyright © Rusan Pharma. Designed by: Exavibes